Peer-Reviewed Journal Articles
Published in Internationally Recognized Peer-Reviewed Journals
Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry
Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
Machine learning reveals distinct gene signature profiles in lesional and nonlesional regions of inflammatory skin diseases
Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus
The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus
Deconvoluting the heterogeneity of SLE: The contribution of ancestry
Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries
COVID-19 Patients Exhibit Unique Transcriptional Signatures Indicative of Disease Severity
Medelian Randomization and Pathway Analysis Demonstrate Shared Genetic Associations Between Systemic Lupus Erythematosus and Coronary Artery Disease
Transcriptomics data: pointing the way to subclassification and personalized medicine in systemic lupus erythematosus
Molecular endotypes of type 1 and type 2 SLE
Lupus Precision Medicine Products (setting the stage for LuGENE®)
Addressing Lupus Pillars for Health Advancement (ALPHA) Project: Lupus Clinical Trial Outcome measures and the patient perspective
Lupus Sci. Med. 10: e000901, 2023.
https://lupus.bmj.com/content/10/1/e000901
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares and enrich trials in lupus
Curr Opin Rheum 32, 2022.
https://pubmed.ncbi.nlm.nih.gov/36001343/
Diagnosis of Systemic Lupus Erythematosus in the Age of Precision Medicine
Diagnoses Without Names, pp. 77-87, 2022.
https://link.springer.com/chapter/10.1007/978-3-031-04935-4_8/
Increasing ancestral diversity in SLE Clinical Studies ArthritisCare & Research 74: 420-426.
https://onlinelibrary.wiley.com/doi/10.1002/acr.24474
Current Status of the Evaluation and Management of Lupus Patients and Future Prospects
Frontiers in Medicine 8:682544, 2021.
https://www.frontiersin.org/articles/10.3389/fmed.2021.682544/full
ANA testing in the classification of patients with SLE
Ann. Rheum. Dis 80:e124, 2021.
New insights into the role of antinuclear antibodies in SLE
Nat. Rev. Rheumatol. 16:565, 2020.
Current challenges in the development of new treatments for lupus
Ann.Rheum.Dis. 78:729, 2019.
Biomarkers as entry criteria for clinical trials of new therapies for systemic lupus erythematosus
Arthritis and Rheumatism 69:487, 2017.
Are Autoantibodies the Targets of B Cell Directed Therapy?
Nature Reviews Rheumatology 7: 1610, 2013.
Medical Affairs for LuGENE-Dx®
Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies
Arthritis Care Res. 74:420, 2022.
doi: 10.1002/acr.24474.
Deconvoluting the heterogeneity of SLE: the contribution of ancestry
Journal of Allergy and Clinical Immunology, 2021
https://doi.org/10.1016/j.jaci.2021.11.005
Patient ancestry significantly contributes to molecular heterogeneity of Systemic Lupus Erythematosus
JCI Insights 5(15) e140380, 2020
10.1172/jci.insight.140380.
Engaging African ancestry participants in SLE clinical trials
Lupus Sci. Med. 5:e000297, 2018
doi: 10.1136/lupus-2018-000297.
COVID-19 Patients Exhibit Unique Transcriptional Signatures Indicative of Disease Severity
Science Advances
Comprehensive transcriptomic analysis of COVID-19 Blood, Lung and Airway
Nature Scientific Reports 11:7052, 2021
https://www.nature.com/articles/s41598-021-86002-x | bioRxiv. 2020 Jun 2: 2020.05.28.121889. doi: 10.1101.2020.05.28.121889.